Screener
XPH vs XLV
State Street SPDR S&P Pharmaceuticals ETF vs State Street Health Care Select Sector SPDR ETF
Key differences
- XLV costs 0.27% less per year.
- XLV is significantly larger than XPH — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, XPH has delivered higher annualized returns.
- XLV has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| XPH | XLV | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.08% |
| Fund size (AUM) | $355M | $37.9B |
| Since | 2006 | 1998 |
| Dividend yield | 0.65% | 1.72% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +46.3% | +15.9% |
| CAGR 3Y | +13.8% | +6.3% |
| CAGR 5Y | +4.5% | +5.7% |
| Sharpe 3Y | 0.57 | 0.26 |
| Volatility 1Y | 21.29% | 14.55% |
| Max drawdown | -35.96% | -28.40% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XPH and XLV
Explore further